A Randomized Phase II Study Evaluating Different Schedules of Nab-Paclitaxel in Metastatic Breast Cancer (SNAP Trial)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Jun 2017
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms SNAP
- 07 Jun 2017 Biomarkers information updated
- 04 Jun 2016 This trial was completed in Spain.
- 14 Aug 2015 According to the ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.